193 related articles for article (PubMed ID: 33919109)
1. Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44
Koh MZ; Ho WY; Yeap SK; Ali NM; Boo L; Alitheen NB
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33919109
[TBL] [Abstract][Full Text] [Related]
2. Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment.
Koh MZ; Ho WY; Yeap SK; Ali NM; Yong CY; Boo L; Alitheen NB
Pathol Res Pract; 2022 May; 233():153854. PubMed ID: 35398617
[TBL] [Abstract][Full Text] [Related]
3. Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.
Sai S; Vares G; Kim EH; Karasawa K; Wang B; Nenoi M; Horimoto Y; Hayashi M
Mol Cancer; 2015 Sep; 14():166. PubMed ID: 26338199
[TBL] [Abstract][Full Text] [Related]
4. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer
Bai J; Chen WB; Zhang XY; Kang XN; Jin LJ; Zhang H; Wang ZY
World J Stem Cells; 2020 Jan; 12(1):87-99. PubMed ID: 32110277
[TBL] [Abstract][Full Text] [Related]
5. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
[TBL] [Abstract][Full Text] [Related]
8. Novel strategies to target chemoresistant triple-negative breast cancer.
Venkatesh J; Rishi AK; Reddy KB
Genes Cancer; 2020 Dec; 11(3-4):95-105. PubMed ID: 33488948
[TBL] [Abstract][Full Text] [Related]
9. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2.
Koh SY; Moon JY; Unno T; Cho SK
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875792
[TBL] [Abstract][Full Text] [Related]
10. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
11. KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells.
Jiang M; Zhuang H; Xia R; Gan L; Wu Y; Ma J; Sun Y; Zhuang Z
Oncotarget; 2017 Nov; 8(54):92106-92118. PubMed ID: 29190901
[TBL] [Abstract][Full Text] [Related]
12. Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells.
Sulaiman A; McGarry S; Chambers J; Al-Kadi E; Phan A; Li L; Mediratta K; Dimitroulakos J; Addison C; Li X; Wang L
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806648
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem cell-like prevalence.
Petrella PE; Chen JW; Ravelo GO; Cosgrove BD
bioRxiv; 2024 Apr; ():. PubMed ID: 38746322
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
15. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
[TBL] [Abstract][Full Text] [Related]
16. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
[TBL] [Abstract][Full Text] [Related]
17. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
18. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells.
Yin S; Cheryan VT; Xu L; Rishi AK; Reddy KB
PLoS One; 2017; 12(8):e0183578. PubMed ID: 28817737
[TBL] [Abstract][Full Text] [Related]
19. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
20. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
